Prince Died From a Drug Overdose. This “Miracle” Drug Could Save Others.

Doctors have known about it for decades.

Jakob Joergensen/AP

Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.

Update, 6/2/16, 10:42 a.m.: The Minneapolis Star Tribune and Associated Press report that Prince died from an opioid overdose. The autopsy and toxicology results have yet to be released publicly.

Doctors treated Prince for a drug overdose just six days before his death, TMZ reported late Thursday citing multiple unnamed sources.

The seven-time Grammy winner, best known for his eccentric personality and gifted songwriting that helped define pop music, was found unresponsive in an elevator at his Paisley Park estate and studio in Minnesota. An autopsy on Friday will help determine the exact cause of death, though information won’t be available for several days, even weeks.

News of the possible drug overdose comes during an unprecedented surge in US deaths linked to opioids, such as heroin and OxyContin. The sharp rise in overdoses has fueled a debate about making the reversal drug, which may have been used on the pop star, more widely available.

Early reports from TMZ and the Pioneer Press stated that Prince had been battling the flu for several weeks, and the pop icon told an Atlanta crowd on April 14 that he had been “a little under the weather” a week before, according to the New York Times.

Just after 1 a.m. the following day, on his way back to Minnesota after two shows in Atlanta, the pop icon made an emergency stop at a hospital in Moline, Illinois. The celebrity news site TMZ, which first broke the news of the pop icon’s death, reported that doctors reportedly injected the 57-year-old with a “save shot” to counteract the damaging effects of an opiate overdose of Percocet, a prescription painkiller with a combination of oxycodone and acetaminophen. Prince was treated and released from the hospital three hours after his arrival.

Communities across the United States are grappling with an opioid overdose epidemic. Such overdoses took more American lives than traffic accidents in 2014, and since 1999 these deaths have nearly quadrupled nationwide, with a surge particularly among young white men. The uptick in overdoses has prompted states and cities to make Naloxone, the so-called injectable “miracle drug” used in hospitals for decades, more accessible for use outside the hospital. Naloxone can save a user’s life by reversing the effects of opiates.

The Obama administration has invested $11 million toward aiding states with expanding treatment services while lawmakers and law enforcement agencies have pushed to give schools and police officers access to the reversal drug.

As my colleague Jenny Luna notes, once doctors inject the drug into the user’s system, it blocks the narcotic’s pathways to the brain and can restore normal breathing levels and consciousness if administered early enough.

You can read her story about the drug here.


Headshot of Editor in Chief of Mother Jones, Clara Jeffery

It sure feels that way to me, and here at Mother Jones, we’ve been thinking a lot about what journalism needs to do differently, and how we can have the biggest impact.

We kept coming back to one word: corruption. Democracy and the rule of law being undermined by those with wealth and power for their own gain. So we're launching an ambitious Mother Jones Corruption Project to do deep, time-intensive reporting on systemic corruption, and asking the MoJo community to help crowdfund it.

We aim to hire, build a team, and give them the time and space needed to understand how we got here and how we might get out. We want to dig into the forces and decisions that have allowed massive conflicts of interest, influence peddling, and win-at-all-costs politics to flourish.

It's unlike anything we've done, and we have seed funding to get started, but we're looking to raise $500,000 from readers by July when we'll be making key budgeting decisions—and the more resources we have by then, the deeper we can dig. If our plan sounds good to you, please help kickstart it with a tax-deductible donation today.

Thanks for reading—whether or not you can pitch in today, or ever, I'm glad you're with us.

Signed by Clara Jeffery

Clara Jeffery, Editor-in-Chief

payment methods

We Recommend